(Circulation. 2005;111:8-10.)
© 2005 American Heart Association, Inc.
Editorial |
From the Division of Cardiovascular Disease and Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn.
Correspondence to Amir Lerman, MD, Division of Cardiovascular Disease and Department of Internal Medicine, Mayo College of Medicine, 200 First St SW, Rochester, MN 55902. E-mail lerman.amir@mayo.edu
Key Words: Editorials restenosis stents endothelium
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Atherosclerosis is a chronic, systemic, and diffuse disease with focal complications in different vascular beds. The precise mechanisms by which a specific site is rendered more prone to the development of symptomatic disease and cardiovascular events are not known. Both the systemic and local manifestations of the disease can vary, depending on the stage, location, and other factors affecting the integrity of the vascular wall. Atherosclerosis, and specifically coronary atherosclerosis, can be manifested as endothelial dysfunction at the very early stage of the disease and as in-stent restenosis at the later stage. Both endothelial dysfunction and in-stent restenosis are pathophysiological processes that involve the vascular wall, may share common pathways, and may be regarded as an abnormal vascular response or healing to injury. However, the treatment effect of mechanical coronary interventions is generally confined to discrete coronary artery segments, whereas the pathological process of coronary atherosclerosis is diffuse. Coronary interventional therapy should thus constitute a part of a comprehensive strategy that includes additional therapeutic approaches, such as intensive efforts to lower lipid levels, which may halt the generalized progression of disease and reduce the risk of death or myocardial infarction.
See p 70
The ability to predict restenosis and thus the local response of the vascular wall to injury remains a major and an important target in cardiovascular disease, not only because of the potential to predict clinical events but also as a clue to the mechanism of the disease. One of the early indications that vascular reactivity may predict
Related Article:
Circulation 2005 111: 70-75.
This article has been cited by other articles:
![]() |
S Lavi, J-H Bae, C S Rihal, A Prasad, G W Barsness, R J Lennon, D R Holmes Jr, and A Lerman Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques Heart, September 15, 2009; 95(18): 1525 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kitta, T. Nakamura, Y. Kodama, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, Y. Ichigi, et al. Endothelial Vasomotor Dysfunction in the Brachial Artery Is Associated With Late In-Stent Coronary Restenosis J. Am. Coll. Cardiol., August 16, 2005; 46(4): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |